Low Serum Alpha-1 Antitrypsin Associated with Anti-PR-3 ANCA in Autistic Children with GI Disease

Genomics Insights

Volumn 2, Issue 1, 2009, Pages 1-9

  Russo, A J ^a   Krigsman, A ^b   Jepson, B ^b   Wakefield, Andrew ^b  

^a Pfeiffer Treatment Center   (United States)

^b Thoughtful House Center for Children   (United States)

Author keywords

Alpha 1 antitrypsin; Autism; GI disease; PR3

Indexed keywords

EID: 83455265454     PISSN: None     EISSN: 11786310     Source Type: Journal    
DOI: 10.4137/gei.s2918     Document Type: Article

References (37)

1. Blank C A, Brantley, M. Clinical features and molecular characteristics of 1-antitrypsin deficiency. Ann Allergy. 1994;72:105-20.
2. Massi G, Chiarelli C. Alphal-antitrypsin: molecular structure and the Pi system. Ada Paediatr Suppl. 1994;393:1-4.
3. Carrell RW. Alphal-antitrypsin: molecular pathology, leukocytes, and tissue damage. J Clin Invest. 1986;78:1427-31.
4. Brantly M, Nukiwa T, Crystal RG. Molecular basis of alpha-1-antitrypsin deficiency. Am J Med. 1998;84(Suppl 6A):13-31.
5. Kurachi K, Chandra T, Degen SJ, et al 1981. Cloning and sequence of cDNA coding for alpha 1-antitrypsin. Proc Natl Acad Sci U S A. 1981;78:6826-30.
6. Silverman GA, Bird PI, Carrell RW, et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem. 2001;276:33293-6.
7. Billingsley GD, Walter MA, Hammond GL, et al. Physical mapping of four serpin genes: alpha 1-antitrypsin, alpha 1-antichymotrypsin, corticosteroidbinding globulin, and protein C inhibitor, within a 280-kb region on chromosome I4q32.1. Am J Hum Genet. 1993;52:343-53.
8. van der Woude FJ, Rasmussen N, Lobatto S, et al. The TH. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985;23;1(8426): 425-129.
9. Rao NV, Wehner NG, Marshall BC, Gray WR, Gray BH, Hoidal JR. Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J Biol Chem. 1991;25;266(15): 9540-48.
10. Esnault VL, Testa A, Audrain M, et al. Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int. 1993; 43(6):1329-32.
11. Savige JA, Chang L, Cook L, Burdon L, Daskalakis M, Doery J. Alpha 1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin Exp Immunol. 1995;100(2):194-7.
12. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiolical potential. Kidney Int. 1994;46:1-15.
13. Kallenberg CGM, Mulder AHL, Cohen Tervaert JW. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med. 1992;93:675-82.
14. Saxon A, Shanahan F, Landers CJ, et al. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 1990;86:202-10.
15. Rump JA, Schölmerich J, Gross V, et al. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiol. 1990;181:406-13.
16. Duerr RH, Targan SR, Landers CJ, et al. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterol. 1991;100:1385-91.
17. Mulder AHL, Horst G, Haagsma EB, et al. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatol. 1993;17:411-7.
18. Roozendaal C, Van Milligen de Wit AWM, Haagsma EB, et al. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features. Am J Med. 1998;105:393-9. [PubMed].
19. Lassoued S, Sixou L, Oksman F, et al. Antineutrophil cytoplasmic antibodies and antibodies to myeloperoxidase in rheumatoid arthritis. Arthritis Rheum. 1991;34:1069-70.
20. Mulder AHL, Horst G, Van Leeuwen MA, et al. Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: characterization and clinical correlates. Arthritis Rheum. 1993;36:1054-60.
21. Schnabel A, Csernok E, Isenberg DA, et al. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus: prevalence, specificities, and clinical significance. Arthritis Rheum. 1995;38:633-7.
22. Spronk PE, Bootsma H, Horst G, et al. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Br J Rheumatol. 1996;35:625-31.
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington D.C: American Psychiatric Association. 1994.
24. Gillberg C, Coleman M. The Biology of the Autistic Syndromes, 2nd edn. London: Mac Keith Press. 1992.
25. Filipek P, Accardo P, Baranek G, et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord. 1999;29(6):439-84.
26. Bailey A, Phillips W, Rutter M. Autism: towards an integration of clinical, genetic, neuro-psychological, and neurobiological perspectives. J Child Psychol Psychiatry. 1996;(1):89-126.
27. Horvath, K and Perman, J, Autistic disorder and gastrointestinal disease. Curr Opin Pediat. 2002;14:(5):583-7.
28. Molloy, C. Manning-Courtney P, Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism. 2003;7:(2):165-71.
29. Valicenti-McDermott, M, Me Vicar, K, Rapin, I. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr. 2006;27: (Suppl 2):S128-36.
30. Esnault, V, Testa, A, Audrain, M,Christophe Rogé, et al. Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney International. 1993;43, 1329-32; doi: 10.1038/ki. 1993.186.
31. JA Savige, L Chang, L Cook, J Burdon, M Daskalakis, J Doery. Alpha 1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin Exp Immunol. 1995;100(2):194-7.
32. Baillieux BEPB, Hagen EC, Kleijburg-van der Keur C, van der Woude FJ, Daha MR. Isolation of a protein complex from purulent sputum consisting of proteinase 3 and alpha 1-antitrypsin and its use for the determination of anti-neutrophil cytoplasmic antibodies. In: Gross WL, ed. ANCA-associated vasculitides: immunodiagnos- tic and pathogenetic value of anti-neutrophil cytoplasmic antibodies. London: Plenum Press, 1993.
33. O'Donoghue DJK, Guckian M, Blundell G, Winney RJ. Alpha 1- antiproteinase and pulmonary haemorrhage in systemic vasculitis. In: Gross WL, ed. ANCA-associated vasculitides: immunodiagnostic and pathogenetic value of antineutrophilcytoplasmicanti-bodies. London: Plenum Press, 1993.
34. Testa A, Audrain M, Baranger T, Sesboue R, Martin J-P, Esnault VLM. Anti-neutrophil cytoplasm antibodies and alpha I-antitrypsin phenotype. Clin Exp Immunol. 1993;93:16A(Suppl).
35. Segelmark M, Elzouki A-N, Wieslander J, Eriksson S. Increased mortality of PR3-ANCA-positive patients with the PiZ gene for alpha-1 antitrypsin. JASN. 1994;5:842A.
36. Russo AJ, Neville L, Wroge C, Low Serum Alpha-1 Antitrypsin (AAT) in Family Members of Individuals With Autism Correlates with PiMZ Genotype. Biomarker Insights. 2009;4:45-56.
37. Russo AJ, Krigsman A, Jepson B, Wakefield A. Anti-PR3 and Anti-MPO IgG ANCA in Autistic Children With Chronic GI Disease, Immunology and Immunogenetics Insights. 2009;2:21-28.